Work

Principles and considerations for effective academia‐industry collaboration in pharmacoepidemiology

Year: 2018

Type: article

Abstract: The complexity of biomedical research has led to increasing recognition that advances in human health can benefit from effective scientific interchange between academic institutions and industry. This scientific collaboration may inform all types of medical research, including pharmacoepidemiology. Though the potential value of academia‐industry collaboration is generally apparent, all stakeholders recognize that research activities must be conducted in a manner that adheres to the principles of sound scientific methods and ethical requirements while, at the same time, acknowledging the missions and responsibilities of the involved parties

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.4644

Authors: Sara A. Ephross, Allen A. Mitchell, Susan Sacks, Walter Straus, Til Stürmer

Institutions: Boston University, Merck & Co., Inc., Rahway, NJ, USA (United States), University of North Carolina at Chapel Hill

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2890365774

FWCI: 0.267

Cites: 4

Cited by: 1

Related to: 10